Compass Pathways Appoints Kelley Boucher as Chief People Officer
Key Highlights
- ➤Compass Pathways (CMPS) appoints Kelley Boucher chief people officer, effective today
- ➤NDA submission for COMP360 psilocybin planned in fourth quarter
- ➤COMP360 psilocybin launch targeted first half of 2027, subject to FDA approval
Expert Statements
Kabir Nath, Chief Executive Officer at Compass Pathways
“We are thrilled to welcome Kelley to our executive team at this pivotal moment in Compass’ journey. As we prepare for our NDA submission in the fourth quarter of this year, we are closer than ever to achieving our goal of introducing an entirely new treatment model in mental health care with COMP360 psilocybin.”
Kabir Nath, Chief Executive Officer at Compass Pathways
“Reaching this critical inflection point requires our team to operate at the highest level, together. Kelley brings the right approach to people leadership to foster and build upon the culture of collaboration and support we’ve created at Compass, as well as to expand our capabilities in support of our expected transition from a clinical pioneer to a commercial stage company. Most importantly, Kelley understands that our people are central to realizing our vision of futures filled with possibilities for people living with serious mental health conditions.”
Kelley Boucher, Chief People Officer at Compass Pathways
“It’s incredibly energizing and an honor to join a team working towards the potential to meaningfully change lives for people who have not found relief from existing psychiatric treatments.”
Kelley Boucher, Chief People Officer at Compass Pathways
“I’m inspired by the purpose and passion that brings people to Compass, and the responsibility to deliver for patients that comes with it. I look forward to building upon the company’s strong culture, and fostering an environment where our people can bring their best, support and motivate each other, and work together to carry Compass forward into its next chapter.”
Compass Pathways Appoints Kelley Boucher as Chief People Officer
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced the appointment of Kelley Boucher as Chief People Officer, effective today. This appointment strengthens the Compass executive team as the company continues to scale in support of its mission to bring the first classic psychedelic treatment to the field of psychiatry. In this role, Ms. Boucher will oversee the Company’s people strategy, with an initial focus on guiding its planned evolution towards the launch of COMP360 psilocybin, subject to FDA approval, in the first half of 2027.
Get started
Create a free account to read the full story.
